Praxis Precision Medicines, Inc. PRAX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -35.3%+10.5pp | -45.8%+29.4pp | -75.2%-14.2pp | -61%+2.6pp | -63.6%+7.4pp | |
| Return on assets | -33.7%+9.0pp | -42.7%+24.5pp | -67.2%-11.0pp | -56.2%+2.1pp | -58.3%+5.7pp | |
| Return on invested capital | -62.2%+24.6pp | -86.8%— | —— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 15.9×+5.7× | 10.2×+5.0× | 5.2×-1.1× | 6.3×-2.1× | 8.4×-2.3× | |
| Quick ratio | 15.9×+5.7× | 10.2×+5.0× | 5.2×-1.1× | 6.3×-2.1× | 8.4×-2.3× | |
| Cash ratio | 10.7×+4.7× | 6×+3.1× | 2.8×-0.4× | 3.2×-1.0× | 4.2×-1.5× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $48.82+25.1% | $39.02+150% | $15.63-17.0% | $18.82-9.8% | $20.86-16.1% | |
| Valuation | ||||||
| Market capitalization | $8.97B+21.7% | $7.37B+561% | $1.12B+24.6% | $895.42M+17.3% | $763.58M-46.8% | |
| Enterprise value | $8.44B+20.3% | $7.01B+626% | $966.12M+30.8% | $738.34M+23.3% | $598.67M-50.9% | |
| Price / book | 6.4×-2.0× | 8.4×+5.1× | 3.2×+1.0× | 2.2×+0.5× | 1.7×-1.5× | |
| Free cash flow yield | -3.1%+0.2pp | -3.4%+17.1pp | -20.5%+0.9pp | -21.4%+0.1pp | -21.5%-12.3pp | |
| Earnings yield | -3.6%+0.5pp | -4.1%+20.4pp | -24.5%+3.6pp | -28%-0.2pp | -27.8%-15.1pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Praxis Precision Medicines, Inc.'s ratios come from?
- Every ratio is computed from Praxis Precision Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.